Camilla Simpson

Camilla V.
Simpson is the founder of Rare Strategic LLC, founded in 2019, serving as President & Managing Member.
Current jobs include Chief Executive Officer at Zehna Therapeutics, Inc. since 2021, Independent Director at Spruce Biosciences, Inc. since 2017, Director at Dyve Biosciences, Inc. since 2020, and Independent Director at GRI Bio, Inc. since 2023.
Former jobs include Director at Aristea Therapeutics, Inc., Director at Vallon Pharmaceuticals, Inc., Senior VP & Head-Product Portfolio Development at BioMarin Pharmaceutical, Inc. from 2017 to 2019, and VP-Regulatory Affairs & Business Development at Shire Pharmaceuticals, Inc. Education includes graduate studies at the University of London and undergraduate studies at Kingston University and National University of Ireland Galway.